These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26247222)

  • 1. Paroxysmal perceptual alteration in a schizophrenic patient treated with paliperidone: A case report.
    Benna P; Rubino E; Marino C; Montalenti E; Giovanna Caprioli M; Rainero I; Pinessi L
    Ann Clin Psychiatry; 2015 Aug; 27(3):223-4. PubMed ID: 26247222
    [No Abstract]   [Full Text] [Related]  

  • 2. Paliperidone-Related Sudden Elevation of Plasma D-Dimer Levels: A Case Report.
    Wu C; Lai J; Ma S; Huang M; Hu S; Xu Y
    J Clin Psychopharmacol; 2020; 40(5):506-507. PubMed ID: 32826483
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.
    Langley-DeGroot M; Joshi Y; Lehman D; Rao S
    J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124
    [No Abstract]   [Full Text] [Related]  

  • 4. Two long-acting injectable antipsychotics for schizophrenia.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):152-3. PubMed ID: 26529133
    [No Abstract]   [Full Text] [Related]  

  • 5. Paliperidone palmitate use in pregnancy in a woman with schizophrenia.
    Özdemir AK; Pak ŞC; Canan F; Geçici Ö; Kuloğlu M; Gücer MK
    Arch Womens Ment Health; 2015 Oct; 18(5):739-40. PubMed ID: 25599999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine, a controversial gold standard antipsychotic for the 21st century: Switching to paliperidone palmitate 3-monthly improves the metabolic profile and lowers antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Schizophr Res; 2019 Oct; 212():234-236. PubMed ID: 31421972
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothermia Associated With Paliperidone Depot Injection in Schizophrenia Patient: A Case Report.
    Hirapara K; Munir A; Aggarwal R
    J Clin Psychopharmacol; 2020; 40(1):86-87. PubMed ID: 31834087
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    Asian J Psychiatr; 2018 Jun; 35():28. PubMed ID: 29751217
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed-onset of psychopharmacologically induced priapism: A cautionary case report.
    Birur B; Fargason RE; Moore N
    Asian J Psychiatr; 2015 Oct; 17():106. PubMed ID: 26188724
    [No Abstract]   [Full Text] [Related]  

  • 10. The possibility of the treatment for long-acting injectable antipsychotics induced severe side effects.
    Omi T; Kanai K; Kiguchi T; Nishida T; Fujimi S; Matsunaga H
    Am J Emerg Med; 2017 Aug; 35(8):1211.e1-1211.e2. PubMed ID: 28460810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia.
    Alphs L; Mao L; Lynn Starr H; Benson C
    Schizophr Res; 2016 Feb; 170(2-3):259-64. PubMed ID: 26742509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report.
    Mirza H; Harding D; Al-Balushi N
    Sultan Qaboos Univ Med J; 2018 May; 18(2):e208-e210. PubMed ID: 30210852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Dependent Paliperidone Associated With Angioedema.
    Yucel A; Yucel N; Ozcan H; Saritemur M
    J Clin Psychopharmacol; 2015 Oct; 35(5):615-6. PubMed ID: 26125544
    [No Abstract]   [Full Text] [Related]  

  • 14. Delirium with anticholinergic symptoms after a combination of paliperidone and olanzapine pamoate in a patient known to smoke cannabis: an unfortunate coincidence.
    Kokalj A; Rijavec N; Tavčar R
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersexuality associated with paliperidone.
    Çayköylü A; Karslıoğlu EH; Özer İ; Köksal AG
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):109-112. PubMed ID: 29389211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 17. The Delirium Related to Oral Paliperidone in Dementia: A Case Report.
    Tsai MC; Chang PT; Yang CH; Liu ME
    J Clin Psychopharmacol; 2016 Apr; 36(2):184-5. PubMed ID: 26872118
    [No Abstract]   [Full Text] [Related]  

  • 18. Paliperidone-related Pisa syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):129-31. PubMed ID: 23288235
    [No Abstract]   [Full Text] [Related]  

  • 19. Paliperidone Palmitate and Metabolic Syndrome in Patients With Schizophrenia: A 12-Month Observational Prospective Cohort Study.
    Rosso G; Pessina E; Martini A; Di Salvo G; Maina G
    J Clin Psychopharmacol; 2016 Jun; 36(3):206-12. PubMed ID: 27043122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization rates.
    Bressington D; Stock J; Hulbert S; MacInnes D
    Int Clin Psychopharmacol; 2015 Jul; 30(4):230-6. PubMed ID: 25882381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.